CELZCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. · Nasdaq Capital Market · $3.06M mkt cap
Assessed Nov 10, 2026 · Float drift
Is the float you're seeing correct?
6.56M
Actual float

Outstanding shares from the 11/6/2026 cover, minus common shares actually held by insiders (Warbington direct + CAC + CMH, Finger, Dickerson net of derivatives).

Confirmed · within 2%
6.40M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener's float is right for CELZ. Trade off 6.56M shares. What it does not show you is what is about to be added to it.

Dilution risk5/10ELEVATED
CONFIDENCE: HIGH

The float your screener shows is right, at 6.56M. 1 floorless convertible note and 3 reverse splits can add another 144% of the float.

  • Serial financing cadence / warrant repricing. Three Roth-led warrant inducements in 16 months, each cutting the strike ($4.42 → $3.75 → $2.86 → $1.60) and issuing 2–2.5x replacement warrants.

  • Registered warrant overhang. 5,580,680 inducement-warrant shares (85% of tradeable float) are registered for resale and exercisable since 2026-08-28.

  • Rapid share count growth. Shares outstanding went from 2,580,532 (11/2025) to 7,597,557 (11/2026), +194% in 12 months, and from 1,748,428 (12/2024) overall (~4.3x).

From today's float to the ceiling

shares
6.56M
Actual float
tradeable today
+0 can sell now
6.56M
Effective supply
float plus what sells on notice
+9.52M if floors are cut and warrants exercise
16.09M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
6.56M
Can sell now
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
6.56M
Converts only if floors are cut
Convertible notes
At the stated conversion prices; a cut to those prices raises the count.
+933.6K
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+8.48M
Options and RSUs
Employee equity; vests and settles over time.
+11.2K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+101.7K
Fully diluted
16.09M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$3.06M
Shares outstanding
7.60M
Reported float
6.40M
Avg volume
79.1K
Reverse splits
3 · latest 1-for-10 · Jun 12, 2023
Going concern
No
Quarterly burn
$1.66M

Market data as of Nov 22, 2026

Key dates

  • Mar 24, 2027 · 1,000,000 unregistered shares (13% of outstanding) went to the CEO's wholly owned CAC for a BioDefense stake. The company booked them as $9…

New to these numbers?

The full free course